Abstract:
A process for making a complexing agent with an enantiomeric excess of at least 60%, wherein said process comprises the following steps: (a) reacting an aqueous slurry of alanine with an enantiomeric excess of at least 60% with formaldehyde and hydrocyanic acid, thereby forming an aqueous solution of alanine- bisacetonitrile, (b) saponifying the alanine-bisacetonitrile from step (a) by combining the aqueous solution obtained in step (a) with an aqueous solution of alkali metal hydroxide.
Abstract:
Process for making a powder or granule containing at least one chelating agent selected from alkali metal salts of methyl glycine diacetic acid (MGDA) and glutamic acid diacetate (GLDA) and iminodisuccinic acid (IDS), said process comprising the steps of (a) introducing an aqueous solution or aqueous slurry of the respective chelating agent (A) into a spray-dryer or spray-granulator, and removing most of said water by spray-drying or spray granulation using a gas with an inlet temperature of 125 to 250°C, (b) withdrawing powder or granules, respectively, from the spray-dryer or spray-granulator, respectively, (c) separating off fines from said powder or granules, wherein said fines have a maximum particle diameter of 350 µm, (d) separating off lumps from said powder or granules, wherein said lumps have a particle diameter of 1,500 µm or more, (e) milling said lumps to a maximum particle diameter of 500 µm, (f) re-introducing said fines from step (c) and milled lumps from step (e) into the spray-dryer or spray-granulator, wherein the share of fines is in the range of from 0.5 to 20 % by weight of the total chelating agent (A) withdrawn in step (b) and the share of milled lumps is in the range of from 5 to 60% by weight of the total chelating agent (A) withdrawn in step (b).
Abstract:
The present invention is directed towards a process for manufacturing a complexing agent, said process comprising the steps of (a) Providing a nitrile according to general formula (I a) or (I b) (formula I a, I b) With M being selected from alkali metal and hydrogen and combinations thereof, (b) Saponification with a total alkali amount of 2.5 to 2.9 mol of alkali metal hydroxide per mole of nitrile according to general formula (I a) or (I b), respectively, and a pH value in the range of from 9.5 to 11.5 at the end of step (b), (c) Adding an amount of alkali metal hydroxide so that the total alkali content is 2.9 to 3.1 moles per mole nitrile according to general formula(I a) or (I b), respectively, and (d) Allowing further conversion.20
Abstract:
Process for manufacturing a crystalline alkali metal salt of the general formula (I) [R 1 -CH(COO)-N(CH 2 -COO) 2 ]M 1 3 (I) wherein M 1 is selected from alkali metal cations, same or different, R 1 is selected from C 1 -C 4 -alkyl and CH 2 CH 2 COOM 1 , comprising the step of (b) crystallizing said alkali metal salt from an aqueous solution containing in the range of from 5 to 30% by weight of alkali metal hydroxide, referring to said aqueous solution.
Abstract:
Process for making a chelating agent according to the general formula (I), R 1 -CH(COOX 1 )-N(CH2COOX 1 ) 2 wherein R 1 is selected from hydrogen, C 1 -C 4 -alkyl, phenyl, benzyl, CH 2 OH, and CH 2 CH 2 COOX 1 , X 1 is (Μ χ Η 1-χ ), M being selected from alkali metal, x is in the range of from 0.6 to 1, said process comprising the following steps: (a) providing a solid, a slurry or a solution of a compound according to general formula (II a) R 1 -CH(COOX 2 )-N(CH 2 CN) 2 wherein X 2 is (M y H 1-y ), M being selected from alkali metal, y is in the range of from zero to 1, (b) contacting said solid or slurry or solution with an aqueous solution of alkali metal hydroxide, wherein the molar ratio of alkali metal ions to nitrile groups is in the range of from 0.6:1 to 0.95:1, (c) reacting said compound according to general formula (II a) with said alkali metal hydroxide.
Abstract:
Aqueous solution containing in the range of from 60.5 to 75 % by weight of a mixture of trialkalimetal salts of the L-and D-enantiomers of methyl glycine diacetic acid (MGDA), said mixture containing predominantly the respective L-isomer with an enantiomeric excess (ee) in the range of from 3 to 97%, wherein said trialkali metal salts have the general formula (I) [CH 3 -CH(COO)-N(CH 2 -COO) 2 ]K 3-x Na x (I) wherein x is in the range of from zero to 2.9.
Abstract:
Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung von Aminodicarbonsäu- re-N,N-diessigsäuren der allgemeinen Formel I worin X unabhängig voneinander für Wasserstoff oder Alkalimetall steht und n eine Zahl 1 oder 2 bezeichnet. Weiterhin betrifft die Erfindung Aminodicarbonsäure-N,N- diessigsäuren hoher Reinheit. Das erfindungsgemäße Verfahren umfasst die folgenden Schritte: a) Umsetzung einer Aminodicarbonsäure der allgemeinen Formel Il worin X und n die zuvor genannten Bedeutungen haben, mit 0,8 bis 1,2 MoI- Äquivalenten Formaldehyd und mit 0,8 bis 1,2 Mol-Äquivalenten Blausäure; b) Umsetzung des in Schritt a) erhaltenen Reaktionsprodukts mit 0,8 bis 1,2 Mol- Äquivalenten Blausäure und mit 0,8 bis1,2 Mol-Äquivalenten Formaldehyd; c) Hydrolyse des in Schritt b) erhaltenen Reaktionsprodukts.